XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 12,706 $ 13,998
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 6,923 7,736
Amortization of deferred financing costs 77 75
Provision for deferred income taxes 618 0
Change in fair value of equity securities 0 (3,117)
Change in fair value of derivative instruments 1,439 3,523
Loss on the sale of investments 0 2,543
Stock based compensation 113 0
Loss on disposal of property and equipment 24 8
Noncash interest expense 26 26
Changes in operating assets and liabilities:    
Accounts receivable 12,439 (3,295)
Accounts receivable – related parties 1 6
Inventory 8,100 (149)
Income tax receivable 1,940 32
Prepaid expenses 3,382 2,700
Other assets 872 963
Accounts payable (11,043) (14,910)
Accounts payable - related parties 82 (800)
Income tax payable 359 0
Accrued expenses and other current liabilities 6,062 (404)
Deferred revenue (2,705) (2,030)
Other noncurrent liabilities 0 1,553
Net cash provided by operating activities 41,415 8,458
Cash flows from investing activities    
Collateralization of derivative instruments 423 (2,991)
Proceeds from the sale of marketable securities 0 37,701
Proceeds from the sale of property and equipment 6 0
Capital expenditures (10,605) (4,994)
Net cash (used in) provided by investing activities (10,176) 29,716
Cash flows from financing activities    
Payment of dividends (117,285) (7,877)
Deferred financing costs 0 (14)
Net cash used in financing activities (117,285) (7,891)
Net change in cash and cash equivalents (86,046) 30,283
Cash and cash equivalents at beginning of period 219,444 175,640
Cash and cash equivalents at end of period 133,398 205,923
Noncash capital expenditures $ 452 $ 518